NORGES BANK - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 57 filers reported holding G1 THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,225,551
-56.5%
225,7000.0%0.00%
-100.0%
Q3 2022$2,818,993
+90.2%
225,700
+464.2%
0.00%0.0%
Q1 2018$1,482,000
+86.6%
40,0000.0%0.00%
Q4 2017$794,000
-20.3%
40,0000.0%0.00%
Q3 2017$996,000
+42.7%
40,0000.0%0.00%
Q2 2017$698,00040,0000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders